Literature DB >> 33777054

T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19.

Olatz Zenarruzabeitia1, Gabirel Astarloa-Pando1, Iñigo Terrén1, Ane Orrantia1, Raquel Pérez-Garay1, Iratxe Seijas-Betolaza2, Javier Nieto-Arana3, Natale Imaz-Ayo4, Silvia Pérez-Fernández4, Eunate Arana-Arri4, Francisco Borrego1,5.   

Abstract

COVID-19 manifests with a wide diversity of clinical phenotypes characterized by dysfunctional and exaggerated host immune responses. Many results have been described on the status of the immune system of patients infected with SARS-CoV-2, but there are still aspects that have not been fully characterized or understood. In this study, we have analyzed a cohort of patients with mild, moderate and severe disease. We performed flow cytometric studies and correlated the data with the clinical characteristics and clinical laboratory values of the patients. Both conventional and unsupervised data analyses concluded that patients with severe disease are characterized, among others, by a higher state of activation in all T cell subsets (CD4, CD8, double negative and T follicular helper cells), higher expression of perforin and granzyme B in cytotoxic cells, expansion of adaptive NK cells and the accumulation of activated and immature dysfunctional monocytes which are identified by a low expression of HLA-DR and an intriguing shift in the expression pattern of CD300 receptors. More importantly, correlation analysis showed a strong association between the alterations in the immune cells and the clinical signs of severity. These results indicate that patients with severe COVID-19 have a broad perturbation of their immune system, and they will help to understand the immunopathogenesis of COVID-19.
Copyright © 2021 Zenarruzabeitia, Astarloa-Pando, Terrén, Orrantia, Pérez-Garay, Seijas-Betolaza, Nieto-Arana, Imaz-Ayo, Pérez-Fernández, Arana-Arri and Borrego.

Entities:  

Keywords:  CD300a; CD300c; CD300e; COVID-19; NK cells; T cells; granzyme B; monocytes

Mesh:

Substances:

Year:  2021        PMID: 33777054      PMCID: PMC7991729          DOI: 10.3389/fimmu.2021.655934

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  64 in total

Review 1.  Natural killer cell memory in infection, inflammation and cancer.

Authors:  Adelheid Cerwenka; Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2016-01-25       Impact factor: 53.106

2.  Sphingomyelin and ceramide are physiological ligands for human LMIR3/CD300f, inhibiting FcεRI-mediated mast cell activation.

Authors:  Kumi Izawa; Masamichi Isobe; Toshihiro Matsukawa; Shinichi Ito; Akie Maehara; Mariko Takahashi; Yoshinori Yamanishi; Ayako Kaitani; Toshihiko Oki; Ko Okumura; Toshio Kitamura; Jiro Kitaura
Journal:  J Allergy Clin Immunol       Date:  2013-09-12       Impact factor: 10.793

3.  Natural killer cells act as rheostats modulating antiviral T cells.

Authors:  Stephen N Waggoner; Markus Cornberg; Liisa K Selin; Raymond M Welsh
Journal:  Nature       Date:  2011-11-20       Impact factor: 49.962

Review 4.  Expansions of Cytotoxic CD4+CD28- T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection.

Authors:  Iain Broadley; Alejandra Pera; George Morrow; Kevin A Davies; Florian Kern
Journal:  Front Immunol       Date:  2017-03-02       Impact factor: 7.561

5.  Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.

Authors:  Evangelos J Giamarellos-Bourboulis; Mihai G Netea; Nikoletta Rovina; Karolina Akinosoglou; Anastasia Antoniadou; Nikolaos Antonakos; Georgia Damoraki; Theologia Gkavogianni; Maria-Evangelia Adami; Paraskevi Katsaounou; Maria Ntaganou; Magdalini Kyriakopoulou; George Dimopoulos; Ioannis Koutsodimitropoulos; Dimitrios Velissaris; Panagiotis Koufargyris; Athanassios Karageorgos; Konstantina Katrini; Vasileios Lekakis; Mihaela Lupse; Antigone Kotsaki; George Renieris; Danai Theodoulou; Vassiliki Panou; Evangelia Koukaki; Nikolaos Koulouris; Charalambos Gogos; Antonia Koutsoukou
Journal:  Cell Host Microbe       Date:  2020-04-21       Impact factor: 21.023

6.  Identification and Functional Analysis of Human CD56neg NK Cells by Flow Cytometry.

Authors:  Ane Orrantia; Iñigo Terrén; Joana Vitallé; Gabirel Astarloa-Pando; Olatz Zenarruzabeitia; Francisco Borrego
Journal:  STAR Protoc       Date:  2020-10-29

7.  Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19.

Authors:  Elizabeth R Mann; Madhvi Menon; Sean Blandin Knight; Joanne E Konkel; John R Grainger; Tracy Hussell; Christopher Jagger; Tovah N Shaw; Siddharth Krishnan; Magnus Rattray; Andrew Ustianowski; Nawar Diar Bakerly; Paul Dark; Graham Lord; Angela Simpson; Timothy Felton; Ling-Pei Ho; Marc Feldmann
Journal:  Sci Immunol       Date:  2020-09-17

8.  Elevated Exhaustion Levels of NK and CD8+ T Cells as Indicators for Progression and Prognosis of COVID-19 Disease.

Authors:  Mingyue Li; Weina Guo; Yalan Dong; Xiaobei Wang; Die Dai; Xingxing Liu; Yiquan Wu; Mengmeng Li; Wenjing Zhang; Haifeng Zhou; Zili Zhang; Lan Lin; Zhenyu Kang; Ting Yu; Chunxia Tian; Renjie Qin; Yang Gui; Feng Jiang; Heng Fan; Vigo Heissmeyer; Alexey Sarapultsev; Lin Wang; Shanshan Luo; Desheng Hu
Journal:  Front Immunol       Date:  2020-10-14       Impact factor: 7.561

Review 9.  Myeloid cells in sepsis-acquired immunodeficiency.

Authors:  Fabienne Venet; Julie Demaret; Morgane Gossez; Guillaume Monneret
Journal:  Ann N Y Acad Sci       Date:  2020-03-23       Impact factor: 5.691

10.  Decrease of Non-Classical and Intermediate Monocyte Subsets in Severe Acute SARS-CoV-2 Infection.

Authors:  Arianna Gatti; Danilo Radrizzani; Paolo Viganò; Antonino Mazzone; Bruno Brando
Journal:  Cytometry A       Date:  2020-08-14       Impact factor: 4.714

View more
  10 in total

Review 1.  Exploring the Utility of NK Cells in COVID-19.

Authors:  Xuewen Deng; Hiroshi Terunuma; Mie Nieda
Journal:  Biomedicines       Date:  2022-04-26

2.  Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells.

Authors:  Mario Witkowski; Caroline Tizian; Marta Ferreira-Gomes; Daniela Niemeyer; Terry C Jones; Frederik Heinrich; Stefan Frischbutter; Stefan Angermair; Thordis Hohnstein; Irene Mattiola; Philipp Nawrath; Sophie McEwen; Silvia Zocche; Edoardo Viviano; Gitta Anne Heinz; Marcus Maurer; Uwe Kölsch; Robert Lorenz Chua; Tom Aschman; Christian Meisel; Josefine Radke; Birgit Sawitzki; Jobst Roehmel; Kristina Allers; Verena Moos; Thomas Schneider; Leif Hanitsch; Marcus A Mall; Christian Conrad; Helena Radbruch; Claudia U Duerr; Joseph A Trapani; Emanuela Marcenaro; Tilmann Kallinich; Victor M Corman; Florian Kurth; Leif Erik Sander; Christian Drosten; Sascha Treskatsch; Pawel Durek; Andrey Kruglov; Andreas Radbruch; Mir-Farzin Mashreghi; Andreas Diefenbach
Journal:  Nature       Date:  2021-10-25       Impact factor: 69.504

3.  Regulatory T Cells as Predictors of Clinical Course in Hospitalised COVID-19 Patients.

Authors:  Sara Caldrer; Cristina Mazzi; Milena Bernardi; Marco Prato; Niccolò Ronzoni; Paola Rodari; Andrea Angheben; Chiara Piubelli; Natalia Tiberti
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

Review 4.  Coronavirus and Carbon Nanotubes: Seeking Immunological Relationships to Discover Immunotherapeutic Possibilities.

Authors:  Elidamar Nunes de Carvalho Lima; Ana Luiza Moraes Octaviano; José Roberto Castilho Piqueira; Ricardo Sobhie Diaz; João Francisco Justo
Journal:  Int J Nanomedicine       Date:  2022-02-21

5.  Identifying Immunological and Clinical Predictors of COVID-19 Severity and Sequelae by Mathematical Modeling.

Authors:  Noha M Elemam; Sarah Hammoudeh; Laila Salameh; Bassam Mahboub; Habiba Alsafar; Iman M Talaat; Peter Habib; Mehmood Siddiqui; Khalid Omar Hassan; Omar Yousef Al-Assaf; Jalal Taneera; Nabil Sulaiman; Rifat Hamoudi; Azzam A Maghazachi; Qutayba Hamid; Maha Saber-Ayad
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

6.  Immunophenotypic changes of monocytes in myelodysplastic syndrome and clinical significance.

Authors:  Lijuan Li; Shunjie Yu; Xian Hu; Zhaoyun Liu; Xiaoying Tian; Xiaotong Ren; Xinyu Guo; Rong Fu
Journal:  Clin Exp Med       Date:  2022-08-02       Impact factor: 5.057

7.  Mucosal gene expression in response to SARS-CoV-2 is associated with early viral load.

Authors:  Seesandra V Rajagopala; Britton A Strickland; Suman B Pakala; Kyle S Kimura; Meghan H Shilts; Christian Rosas-Salazar; Hunter M Brown; Michael H Freeman; Bronson C Wessinger; Veerain Gupta; Elizabeth Phillips; Simon A Mallal; Justin H Turner; Suman R Das
Journal:  bioRxiv       Date:  2022-08-23

8.  T cell perturbations persist for at least 6 months following hospitalization for COVID-19.

Authors:  Melissa Govender; Francis R Hopkins; Robin Göransson; Cecilia Svanberg; Esaki M Shankar; Maria Hjorth; Åsa Nilsdotter-Augustinsson; Johanna Sjöwall; Sofia Nyström; Marie Larsson
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

9.  Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution.

Authors:  Sara Garcinuño; Francisco Javier Gil-Etayo; Esther Mancebo; Marta López-Nevado; Antonio Lalueza; Raquel Díaz-Simón; Daniel Enrique Pleguezuelo; Manuel Serrano; Oscar Cabrera-Marante; Luis M Allende; Estela Paz-Artal; Antonio Serrano
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

Review 10.  T cells in SARS-CoV-2 infection and vaccination.

Authors:  Arthur Young
Journal:  Ther Adv Vaccines Immunother       Date:  2022-08-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.